Gastrointestinal Infections

Top Story

Surotomycin inferior to vancomycin for C. difficile

February 17, 2017

Findings published in Open Forum Infectious Diseases indicated that surotomycin did not show superiority or noninferiority to vancomycin for treating Clostridium difficile infection.

In the Journals

Freeze-dried FMT capsules effectively treat recurrent C. difficile infection

February 16, 2017
Freeze-dried, encapsulated fecal microbiota was safe and highly effective for the treatment of recurrent Clostridium difficile infection after a single treatment…

Fidaxomicin highly effective for treating C. difficile infection

Infectious Disease News, February 2017
Dificid, a newer antibiotic for treating Clostridium difficile infection, was highly effective for treating initial and recurrent infections, including in patients with…

CRE from US swine farm poses threat of foodborne transmission

Infectious Disease News, February 2017
Researchers detected carbapenem-resistant Enterobacteriaceae, or CRE, at a farrow-to-finish operation in the United States, according to a recently published study…
CME

Differentiating and Managing Diarrhea: A Persistent Dilemma

This activity is supported by an educational grant from Romark, L.C.

Approximately 2-4 billion episodes of infectious diarrhea occur worldwide each year, placing a burden on quality of…
More »
In the Journals

Budesonide an effective alternative steroid in some patients with autoimmune hepatitis

January 25, 2017
Budesonide was an effective alternative steroid for a proportion of patients with autoimmune hepatitis who were…
More »
Featured
Conference on Retroviruses and Opportunistic Infections (CROI)

Conference on Retroviruses and Opportunistic Infections (CROI)

Video
Meeting News Coverage

Early liver transplantation could improve survival rates for patients with alcoholic hepatitis

November 17, 2014
More »
In the Journals Plus

Surotomycin inferior to vancomycin for C. difficile

February 17, 2017
Findings published in Open Forum Infectious Diseases indicated that surotomycin did not show superiority or noninferiority to vancomycin for

In the Journals

Freeze-dried FMT capsules effectively treat recurrent C. difficile infection

February 16, 2017
Freeze-dried, encapsulated fecal microbiota was safe and highly effective for the treatment of recurrent Clostridium difficile infection after a…

Fidaxomicin highly effective for treating C. difficile infection

Infectious Disease News, February 2017
Dificid, a newer antibiotic for treating Clostridium difficile infection, was highly effective for treating initial and recurrent infections…

CRE from US swine farm poses threat of foodborne transmission

Infectious Disease News, February 2017
Researchers detected carbapenem-resistant Enterobacteriaceae, or CRE, at a farrow-to-finish operation in the United States, according to a recently…

Children with type 1 diabetes more likely to have enterovirus infections

Infectious Disease News, February 2017
Study findings show that children with type 1 diabetes had three times the number of enterovirus infections as children without diabetes. “This…

In the Journals

Modeling shows invasive Salmonella vaccine reduces cases, deaths among children

February 10, 2017
A new model used to assess the impact of non-typhoidal Salmonella vaccine campaigns found that implementing a vaccine for invasive strains through

Oral cholera vaccine does not significantly increase risk of pregnancy loss

February 8, 2017
An observational cohort study of pregnant women in Malawi showed no evidence that the oral cholera vaccine Shanchol significantly increased pregnancy…

In the Journals

Vancomycin significantly reduces mortality risk in severe C. difficile infections

February 6, 2017
Vancomycin should be considered as the first-line therapy for patients with severe Clostridium difficile infection rather than routinely prescribed…

CDI microbiome drug trial failure may be explained by misdiagnosis, dosing

February 1, 2017
Seres Therapeutics has revealed complete 24-week data from the phase 2 ECOSPOR trial of its investigational oral microbiome-based therapeutic…

C. difficile vaccine enters phase 3 trial

January 27, 2017
An investigational vaccine for the prevention of Clostridium difficile infection will be evaluated in a phase 3 trial this year after showing…

More Headlines »
Advertisement
Advertisement